Amsphere™ A3 is a high capacity, next generation Protein A chromatography resin for advanced antibody purification with overall improved process robustness and optimized impurity removal.
KBI Biopharma, Inc., accelerates and optimizes drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services in an agile, client-friendly partnering environment. Today they serve more than 200 clients in the US, Canada, Europe, Korea and Japan, including most of the top ten (bio)-pharmaceutical companies. KBI was founded in 1996 and has facilities in Durham and Research Triangle Park, North Carolina and Boulder, Colorado.
KBI’s extensive track record of successful process development and manufacturing programs is a result of their unique approach of applying the insight gained from our biophysical and biochemical protein characterization methodologies, towards the development of robust and scalable processes. KBI delivers expert and integrated process development and cGMP manufacturing of recombinant protein Active Pharmaceutical Ingredients (API) for our clients. KBI’s scientific, quality and regulatory staff offers extensive experience – proven through numerous IND and NDA submissions – to meet the challenges that arise at all stages of drug development.